Comhchiallaigh:

Oclacitinib ?, > 98%; PF-03394197 (oclacitinib); Oclacitinib PF-03394197; JAKi; tras-N-Methyl-4- (meitil-7H-pyrrolo[2,3-d]pirimidin-4-ylamino)-ciocliheacsánamethanesulfóin ;CiocléacsánMeitéinsulfónaMide, N-Meitil-4-(Meitil-7H-pioról[2,3-d]piriMidin-4-ylaMino)-, tras-;N-meitil-1-((1r,4r)-4-(meitil (7H-piorróló[2,3-d]pirimidin-4-il)aimín)ciocliheicsil)meatanesulfónaimíd; N-Meitil-1-(tras-4-(meitil(7H-piorróló[2,3-d]pirimidin-4) -il)aimín)ciocliheicsil)matanesulfónaimíd

SMILES Canonical:CNS(=O)(=O)CC1CCC(CC1)N(C)C2=NC=NC3=C2C=CN3

Dlús:1.316±0.06g/cm3(Tuartha)

PKA:11.59±0.40 (Tuartha)